secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLENO THERAPEUTICS INC (SLNO)
CIK:        0001484565
Form:       8-K
Filed at:   2023-07-10T23:59:59+00:00
Accession:  0001193125-23-184587
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Soleno Therapeutics files 8-K with corporate presentation; no specific results disclosed
--------------------------------------------------------------------------------

- Presentation furnished under Regulation FD; no financial metrics or guidance provided in filing.
- Company is a clinical-stage biotech focused on Prader-Willi syndrome; pipeline update likely in exhibit.
- No material event such as earnings, M&A, or leadership change announced in this 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484565/000119312523184587/0001193125-23-184587-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484565/000119312523184587/d528883d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-184587

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer